A previous transcriptome profiling study demonstrated that neuroblastoma RAS viral oncogene homolog (NRAS) was dysregulated in fibrolamellar HCC, although the functions and clinical implications of NRAS were unknown (Sorenson et al., 2017). This evidence concerns the gene NRAS and hepatocellular carcinoma.